MEDIMI — Medimi AB Income Statement
0.000.00%
Last trade - 00:00- SEK5.48m
- SEK3.30m
- SEK4.83m
Annual income statement for Medimi AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.573 | 1.08 | 2.08 | 3.64 | 4.83 |
| Cost of Revenue | |||||
| Gross Profit | -0.689 | -0.628 | 0.569 | 2.04 | 1.24 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 14.1 | 17.4 | 17.4 | 17.8 | 17.1 |
| Operating Profit | -13.6 | -16.3 | -15.4 | -14.1 | -12.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -13.6 | -16.4 | -15.4 | -14.3 | -12.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.6 | -16.4 | -15.4 | -14.3 | -12.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.6 | -16.4 | -15.4 | -14.3 | -12.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.6 | -16.4 | -15.4 | -14.3 | -12.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.05 | -0.05 | -0.028 | -0.014 | -0.007 |
| Dividends per Share |